tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DE:6MK

CDC plans study into potential vaccines, autism connections, Reuters reports
The FlyCDC plans study into potential vaccines, autism connections, Reuters reports
12h ago
JNJ
MRK
Hold Rating for Merck & Company Amid Keytruda Patent Infringement Concerns
PremiumRatings
Hold Rating for Merck & Company Amid Keytruda Patent Infringement Concerns
2d ago
MRK
Merck’s Keytruda subject of brewing patent dispute with Halozyme, WSJ says
PremiumThe Fly
Merck’s Keytruda subject of brewing patent dispute with Halozyme, WSJ says
3d ago
MRK
HALO
HHS increasing scrutiny of vaccines under RFK Jr., WSJ reports
PremiumThe Fly
HHS increasing scrutiny of vaccines under RFK Jr., WSJ reports
4d ago
JNJ
MRK
Merck price target lowered to $115 from $125 at Berenberg
PremiumThe Fly
Merck price target lowered to $115 from $125 at Berenberg
8d ago
MRK
Medicenna Therapeutics reports clinical data from ABILITY-1 study of MDNA11
PremiumThe FlyMedicenna Therapeutics reports clinical data from ABILITY-1 study of MDNA11
11d ago
MRK
Merck’s application for keytruda in HNSCC granted priority review by FDA
Premium
The Fly
Merck’s application for keytruda in HNSCC granted priority review by FDA
11d ago
MRK
Merck & Co. Buy Rating: Strong Market Position and Growth Potential Driven by Keytruda and Promising Pipeline
Premium
Ratings
Merck & Co. Buy Rating: Strong Market Position and Growth Potential Driven by Keytruda and Promising Pipeline
12d ago
MRK
Positive Outlook for Merck & Co. Driven by Winrevair’s Success and Favorable Trial Results
PremiumRatings
Positive Outlook for Merck & Co. Driven by Winrevair’s Success and Favorable Trial Results
12d ago
MRK
Merck vaccine case linked to Kennedy delayed mid-trial, Reuters reports
PremiumThe Fly
Merck vaccine case linked to Kennedy delayed mid-trial, Reuters reports
17d ago
MRK
Lyft downgraded, Snowflake upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Lyft downgraded, Snowflake upgraded: Wall Street’s top analyst calls
18d ago
FN
GE
Arcus Biosciences price target lowered to $25 from $36 at Morgan Stanley
PremiumThe Fly
Arcus Biosciences price target lowered to $25 from $36 at Morgan Stanley
18d ago
MRK
GILD
Merck receives European Commission approval for WELIREG in two indications
PremiumThe FlyMerck receives European Commission approval for WELIREG in two indications
18d ago
MRK
Deutsche downgrades Merck ahead of Keytruda 2028 expiration
Premium
The Fly
Deutsche downgrades Merck ahead of Keytruda 2028 expiration
18d ago
MRK
ABBV
Merck downgraded to Hold from Buy at Deutsche Bank
Premium
The Fly
Merck downgraded to Hold from Buy at Deutsche Bank
18d ago
MRK
Soros buys Arthur J. Gallagher, boosts Accenture in Q4
PremiumThe Fly
Soros buys Arthur J. Gallagher, boosts Accenture in Q4
21d ago
J
SW
Merck put volume heavy and directionally bearish
PremiumThe Fly
Merck put volume heavy and directionally bearish
22d ago
MRK
Senate votes to confirm Robert Kennedy as head of HHS
PremiumThe Fly
Senate votes to confirm Robert Kennedy as head of HHS
23d ago
JNJ
MRK
April 14, 2025 Deadline: Contact Levi & Korsinsky LLP to Join Class Action Suit Against MRK
PremiumClass Action
April 14, 2025 Deadline: Contact Levi & Korsinsky LLP to Join Class Action Suit Against MRK
23d ago
MRK
Neuphoria Therapeutics to receive $15M payment from Merck
PremiumThe FlyNeuphoria Therapeutics to receive $15M payment from Merck
24d ago
MRK
NEUP
Merck price target lowered to $115 from $122 at Guggenheim
Premium
The Fly
Merck price target lowered to $115 from $122 at Guggenheim
24d ago
MRK
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
26d ago
CI
HD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >